Hong Kong, China

Na Li

This inventor holds 1 USPTO granted patent. Top assignee: The Chinese University of Hong Kong. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Na Li. Retrieved from https://idiyas.com/inventor/na-li-mfqr7pub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Na Li - Innovator in Toxicity Detection

Introduction

Na Li is a prominent inventor based in Hong Kong, CN. She has made significant contributions to the field of toxicity detection, particularly concerning pyrrolizidine alkaloids. Her innovative work has implications for both clinical and research settings.

Latest Patents

Na Li holds a patent for a "Method and assay kit for detection of toxicity induced by pyrrolizidine alkaloids." This patent describes an antibody that specifically recognizes adducts between pyrrole and cellular macromolecules. Such adducts are likely to occur in mammals suffering from pyrrolizidine alkaloid poisoning. The antibody can be produced using a synthetic immunogen conjugated with a pyrrole as a hapten. It can be utilized in an assay kit and serves as a novel means for detecting or diagnosing pyrrolizidine alkaloid poisoning in both clinical and research laboratories. Na Li has 1 patent to her name.

Career Highlights

Na Li is affiliated with The Chinese University of Hong Kong, where she continues her research and development in the field of toxicology. Her work is recognized for its potential to improve diagnostic methods for poisoning cases.

Collaborations

Na Li collaborates with notable colleagues, including Ge Lin and Jiang Zheng, who contribute to her research endeavors.

Conclusion

Na Li's innovative contributions to toxicity detection highlight her role as a leading inventor in her field. Her work not only advances scientific understanding but also enhances diagnostic capabilities in clinical settings.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…